These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29876274)

  • 41. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case.
    Korhonen VE; Solje E; Suhonen NM; Rauramaa T; Vanninen R; Remes AM; Leinonen V
    Fluids Barriers CNS; 2017 Apr; 14(1):10. PubMed ID: 28420385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies.
    Huang SH; Chang CC; Lui CC; Chen NC; Lee CC; Wang PW; Jiang CF
    Clin Nucl Med; 2015 Jan; 40(1):26-31. PubMed ID: 25426755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffusion Tensor Imaging of the Superior Thalamic Radiation and Cerebrospinal Fluid Distribution in Idiopathic Normal Pressure Hydrocephalus.
    Younes K; Hasan KM; Kamali A; McGough CE; Keser Z; Hasan O; Melicher T; Kramer LA; Schulz PE;
    J Neuroimaging; 2019 Mar; 29(2):242-251. PubMed ID: 30461106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
    Fujishiro H; Iseki E; Kasanuki K; Murayama N; Ota K; Suzuki M; Sato K
    Int J Geriatr Psychiatry; 2012 Nov; 27(11):1138-46. PubMed ID: 22250011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
    Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
    J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Novel Deep Learning Approach with a 3D Convolutional Ladder Network for Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Irie R; Otsuka Y; Hagiwara A; Kamagata K; Kamiya K; Suzuki M; Wada A; Maekawa T; Fujita S; Kato S; Nakajima M; Miyajima M; Motoi Y; Abe O; Aoki S
    Magn Reson Med Sci; 2020 Dec; 19(4):351-358. PubMed ID: 31969525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.
    Jagust WJ; Friedland RP; Budinger TF
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1091-6. PubMed ID: 3878390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Gupta V; Verma R; Ranjan R; Belho ES; Seniaray N; Dinand V; Malik D; Mahajan H
    Nucl Med Commun; 2019 Dec; 40(12):1275-1282. PubMed ID: 31633646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia.
    Cerami C; Dodich A; Lettieri G; Iannaccone S; Magnani G; Marcone A; Gianolli L; Cappa SF; Perani D
    Cortex; 2016 Oct; 83():101-12. PubMed ID: 27498041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia.
    Kerklaan BJ; van Berckel BN; Herholz K; Dols A; van der Flier WM; Scheltens P; Pijnenburg YA
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):607-13. PubMed ID: 24576796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.